Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
161.04B
Market cap161.04B
Price-Earnings ratio
36.08
Price-Earnings ratio36.08
Dividend yield
6.31%
Dividend yield6.31%
Average volume
38.36M
Average volume38.36M
High today
$28.44
High today$28.44
Low today
$27.33
Low today$27.33
Open price
$27.58
Open price$27.58
Volume
59.71M
Volume59.71M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$23.58
52 Week low$23.58

Stock Snapshot

The current Pfizer(PFE) stock price is $28.24, with a market capitalization of 161.04B. The stock trades at a price-to-earnings (P/E) ratio of 36.08 and offers a dividend yield of 6.31%.

On 2026-08-19, Pfizer(PFE) stock traded between a low of $27.33 and a high of $28.44. Shares are currently priced at $28.24, which is +3.3% above the low and -0.7% below the high.

The Pfizer(PFE)'s current trading volume is 59.71M, compared to an average daily volume of 38.36M.

During the past year, Pfizer(PFE) stock moved between $23.58 at its lowest and $28.75 at its peak.

During the past year, Pfizer(PFE) stock moved between $23.58 at its lowest and $28.75 at its peak.

PFE News

24/7 Wall St. 4h
Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen?

Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen? By David Moadel Published Aug 19, 3:20PM EDT Quick Read Merck surged 44% YTD, topping Am...

Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen?
Benzinga 5h
Pfizer Stock Rises Wednesday: What's Going On? - Benzinga

...

Pfizer Stock Rises Wednesday: What's Going On? - Benzinga
TipRanks 8h
Pfizer Stock Rallies 4% Thanks to Merck and Moderna’s Cancer Trial Update

Pfizer (PFE) stock was up 3.74% on Wednesday, despite a lack of news from the biopharmaceutical company. However, that doesn’t mean that PFE stock was up withou...

Analyst ratings

62%

of 29 ratings
Buy
31%
Hold
62.1%
Sell
6.9%

More PFE News

Nasdaq 1d
Warren Buffett and Greg Abel Keep Overlooking This Stock -- but It's One of the Most Berkshire-Ready Picks on the Market

Key Points Its current dividend yield is sizeable, and based on a dividend with more resiliency than the market’s presuming. Most drugs have more of a defensi...

Warren Buffett and Greg Abel Keep Overlooking This Stock -- but It's One of the Most Berkshire-Ready Picks on the Market
Simply Wall St 2d
Albert Bourla Bought 9.6% More Shares In Pfizer

Those following along with Pfizer Inc. ( ) will no doubt be intrigued by the recent purchase of shares by Albert Bourla, Chairman of the Board & CEO of the comp...

Albert Bourla Bought 9.6% More Shares In Pfizer
TipRanks 2d
Pfizer Advances Early Obesity Drug PF-08653944 With Phase 1 Study Completion

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

Simply Wall St 3d
Pfizer Stock And 2 AI Healthcare Picks Built Around Productivity Growth

With global bond yields high and borrowing costs less forgiving, capital is flowing toward companies that can raise productivity rather than just cut expenses....

Pfizer Stock And 2 AI Healthcare Picks Built Around Productivity Growth
Simply Wall St 4d
Pfizer Stock Looks Fully Valued At Today’s Price

Pfizer stock has returned roughly 28.4% less over the past five years, yet the current valuation screens as somewhat expensive on market multiples and only mixe...

Pfizer Stock Looks Fully Valued At Today’s Price
TipRanks 4d
Pfizer Insider Buying Surge and Vaccine Wins Ignite Buzz

Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Claim 55% Off TipRanks Unlock powerful investing too...

TipRanks 5d
Opko Health Expands Royalty-Backed Long-Term Note Financing

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.